RE Pratley, A Salsali - Current Medical Research and Opinion®, 2007 - informahealthcare.com University of Vermont College of Medicine, Burlington, VT, USA ... Address for
correspondence: Richard E. Pratley, MD, Professor of Medicine, Director –
Diabetes & Metabolism Translational Medicine Unit, Department of Medicine, ... Cited by 29 - Related articles - BL Direct - All 4 versions
DF Kruger, CL Martin, CE Sadler - The Diabetes Educator, 2006 - tde.sagepub.com This review article describes the regulation of glucose homeostasis in subjects
with and without diabetes based on the emergence of new information and
discusses modes of action, attributes, and limitations of current diabetes ... Cited by 10 - Related articles - All 3 versions
RE Pratley - The Medscape Journal of Medicine, 2008 - pubmedcentral.nih.gov Two classes of therapies target the incretin system. The first, glucagon-like
peptide-1 (GLP-1) agonists (exemplified by exenatide and liraglutide), have
demonstrated considerable efficacy in clinical trials, reducing hemoglobin ... Cited by 8 - Related articles - All 7 versions
RE Pratley, M Gilbert - The Review of Diabetic Studies: RDS, 2008 - pubmedcentral.nih.gov Until recently, the pathogenesis of type 2 diabetes mellitus (T2DM) has been
conceptualized in terms of the predominant defects in insulin secretion and
insulin action. It is now recognized that abnormalities in other hormones ... Cited by 8 - Related articles - All 3 versions
D Maggs, I MacDonald, MA Nauck - Diabetes Obes Metab, 2008 - interscience.wiley.com The gastrointestinal tract is increasingly viewed as a critical organ in glucose
metabolism because of its role in delivering glucose to the circulation and in
secreting multiple glucoregulatory hormones that, in concert with insulin ... Cited by 6 - Related articles - All 3 versions
CA Schnabel, M Wintle, O Kolterman - Vascular Health and Risk Management, 2006 - pubmedcentral.nih.gov Interventional studies have demonstrated the impact of hyperglycemia on the
development of vascular complications associated with type 2 diabetes, which
underscores the importance of safely lowering glucose to as near-normal as ... Cited by 6 - Related articles - BL Direct - All 7 versions
J Green, M Feinglos - International Journal of Clinical Practice-Supplement, 2007 - interscience.wiley.com Type 2 diabetes mellitus, which is increasingly prevalent in the United States
and responsible for the bulk of diabetes-related healthcare costs, has not been
adequately managed over the long term with the most commonly prescribed ... Cited by 5 - Related articles - BL Direct - All 5 versions
DJ Drucker - The Diabetes Educator, 2006 - tde.sagepub.com Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
Add to Technorati What's this? ... From the Banting and Best Diabetes Centre
and the University of Toronto, Toronto, Ontario, Canada. Cited by 5 - Related articles - All 3 versions
- ►sherbornegibbs.com [PDF] CA Schnabel - The British Journal of Diabetes & Vascular Disease, 2005 - dvd.sagepub.com Abstract E xenatide, (BYETTA TM ), is the first in a new class of agents termed
incretin mimetics, which replicate several glucoregulatory effects of the
endogenous incretin hormone, glucagon-like peptide-1 (GLP-1). Currently ... Cited by 5 - Related articles - All 4 versions
J Green, M Feinglos - Vascular Health and Risk Management, 2008 - pubmedcentral.nih.gov Type 2 diabetes mellitus is an increasingly prevalent condition worldwide. The
complications of this disease are known to significantly increase the morbidity
and mortality of those affected, resulting in substantial direct and ... Cited by 3 - Related articles - All 7 versions
